Home / Stocks / SOLV

Solventum (SOLV, Health Care Supplies) Stock Valuation & Fair Value Fairly valued

Solventum (SOLV, Health Care Supplies) trades at a blended P/E of 13.1, about 15% above its historical normal valuation, with a forward growth estimate of 8.1% and a PEG of 1.61.

DATA AS OF 2026-08-21
Blended P/E
13.1
Normal P/E
11.4
PEG
1.61
Fwd growth
8.1%
Div yield
0.0%
RSI (14)
59.5
Neutral

The Street vs SeerForecast

Wall Street's mean price target for SOLV is $93.92 across 13 analysts, 4.9% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-06-03.

Price and rating by weekClose moved +13.1 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 78.36 (recalculated)2026-06-10: Fairly valued, close 80.94 (recalculated)2026-06-14: Fairly valued, close 78.87 (recalculated)2026-06-16: Fairly valued, close 76.56 (recalculated)2026-06-21: Fairly valued, close 75.43 (recalculated)2026-07-02: Fairly valued, close 78.27 (recalculated)2026-07-06: Fairly valued, close 77.94 (recalculated)2026-07-09: Fairly valued, close 75.96 (recalculated)2026-07-12: Fairly valued, close 76.70 (recalculated)2026-07-13: Fairly valued, close 77.42 (recalculated)2026-07-14: Fairly valued, close 76.28 (recalculated)2026-07-20: Fairly valued, close 79.25 (recalculated)2026-07-22: Fairly valued, close 77.64 (recalculated)2026-07-25: Fairly valued, close 78.01 (recalculated)2026-07-27: Fairly valued, close 80.47 (recalculated)2026-07-31: Fairly valued, close 85.44 (recalculated)2026-08-03: Fairly valued, close 85.442026-08-07: Fairly valued, close 82.98 (recalculated)2026-08-10: Fairly valued, close 82.982026-08-14: Fairly valued, close 88.59 (recalculated)2026-08-17: Fairly valued, close 88.5978892026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 12.1+6%Fairly valued
2026-06-10P/E 12.9+13%Fairly valued
2026-06-14P/E 12.9+13%Fairly valued
2026-06-16P/E 12.9+13%Fairly valued
2026-06-21P/E 12.9+13%Fairly valued
2026-07-02P/E 12.4+9%Fairly valued
2026-07-06P/E 12.4+8%Fairly valued
2026-07-09P/E 12.4+8%Fairly valued
2026-07-12P/E 12.1+6%Fairly valued
2026-07-13P/E 12.1+6%Fairly valued
2026-07-14P/E 12.1+6%Fairly valued
2026-07-20P/E 12.8+12%Fairly valued
2026-07-22P/E 12.8+12%Fairly valued
2026-07-25P/E 12.3+7%Fairly valued
2026-07-27P/E 12.3+7%Fairly valued
2026-07-31P/E 13.6+19%Fairly valued
2026-08-03P/E 13.4+18%Fairly valued
2026-08-07P/E 12.3+8%Fairly valued
2026-08-10P/E 12.3+8%Fairly valued
2026-08-14P/E 12.8+12%Fairly valued
2026-08-17P/E 13.1+15%Fairly valued
2026-08-21P/E 13.1+15%Fairly valued ← now

Frequently asked questions

Is Solventum stock overvalued?

At a blended P/E of 13.1 versus its historical normal P/E of 11.4, Solventum trades about 15% above its typical valuation, with a PEG of 1.61 on 8.1% forward growth. tickerseer currently rates it fairly valued.

What is Solventum's fair value and PEG?

Solventum trades at a blended P/E of 13.1 against a historical normal P/E of 11.4, a PEG of 1.61, and a forward growth estimate of 8.1%.

Has tickerseer's rating of Solventum changed?

tickerseer's rating has been fairly valued since 2026-06-03.

What is the analyst price target for Solventum?

The mean Wall Street price target for Solventum is $93.92 across 13 analysts, 4.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track SOLV free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.